SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011219
Filing Date
2022-06-06
Accepted
2022-06-06 16:01:22
Documents
14
Period of Report
2022-06-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20220606.htm   iXBRL 8-K 187628
2 EX-99.1 acet-ex99_1.htm EX-99.1 157382
3 GRAPHIC img94724212_0.jpg GRAPHIC 7255
  Complete submission text file 0000950170-22-011219.txt   502661

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20220606.xsd EX-101.SCH 2472
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20220606_pre.xml EX-101.PRE 10679
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20220606_lab.xml EX-101.LAB 14564
8 EXTRACTED XBRL INSTANCE DOCUMENT acet-20220606_htm.xml XML 5103
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 22998029
SIC: 2834 Pharmaceutical Preparations